IONS

IONS

USD

Ionis Pharmaceuticals Inc. Common Stock

$73.550-0.240 (-0.325%)

السعر في الوقت الحقيقي

Healthcare
التكنولوجيا الحيوية
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$73.790

الأعلى

$75.000

الأدنى

$72.360

الحجم

0.79M

أساسيات الشركة

القيمة السوقية

11.9B

الصناعة

التكنولوجيا الحيوية

البلد

United States

إحصاءات التداول

متوسط الحجم

2.47M

البورصة

NMS

العملة

USD

نطاق 52 أسبوعاً

الأدنى $23.95الحالي $73.550الأعلى $76.78

أخبار ذات صلة

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $100 to $110.

عرض المزيد
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110
Analyst Upgrades

Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77

Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $70 to $77.

عرض المزيد
Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77
Analyst Upgrades

TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99

TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals with a Buy and raises the price target from $59 to $99.

عرض المزيد
TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99
Analyst Upgrades

Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94

Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $90 to $94.

عرض المزيد
Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $95 to $100.

عرض المزيد
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100
Analyst Upgrades

Barclays Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $95

Barclays analyst Gena Wang maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $80 to $95.

Analyst Upgrades

RBC Capital Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $82

RBC Capital analyst Luca Issi maintains Ionis Pharmaceuticals with a Outperform and raises the price target from $80 to $82.

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.